Small Cap Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Aug 12, 2022

Discover small cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

88 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
575Endurance RPHK$0.11-2.7%-35.1%HK$27.3mn/aPS2xn/an/a
8247Biosino Bio-Technology and Science IncorporationHK$1.360%8.8%HK$196.8mn/aPB1xn/a0%
1312Tongfang Kontafarma HoldingsHK$0.039-2.5%-38.1%HK$218.0mn/aPB0.2xn/a0%
858Extrawell Pharmaceutical HoldingsHK$0.09417.5%-13.0%HK$224.7mn/aPE1.7xn/an/a
1011China NT Pharma GroupHK$0.13-1.5%28.0%HK$243.8mn/aPE-1.4xn/a0%
8329Shenzhen Neptunus Interlong Bio-techniqueHK$0.15-2.6%-39.8%HK$248.3mn/aPE6.9xn/an/a
1889Sanai Health Industry GroupHK$0.0866.2%n/aHK$263.8mn/aPE25.2xn/a0%
1643Modern Chinese Medicine GroupHK$0.443.5%-43.6%HK$264.0mn/aPE2.8xn/a3.6%
8225China Health GroupHK$0.31-3.1%-22.5%HK$308.6mn/aPE9xn/an/a
239Pak Fah Yeow InternationalHK$1.26-6.0%-30.4%HK$392.7mn/aPE10.3xn/a5.2%
455Tianda PharmaceuticalsHK$0.180%-1.6%HK$397.8mn/aPB0.5xn/a1.4%
897Wai Yuen Tong Medicine HoldingsHK$0.33-9.6%8.2%HK$406.4mn/aPB0.2xn/a0%
8158China Regenerative Medicine InternationalHK$0.16-3.0%-48.9%HK$459.5mn/aPE9.3xn/an/a
690Uni-Bio Science GroupHK$0.082.6%-20.0%HK$515.5mn/aPS1.4xn/an/a
1498PuraPharmHK$1.420%71.1%HK$560.8mn/aPB1.4xn/a0%
503Lansen Pharmaceutical HoldingsHK$1.37-4.9%-47.5%HK$576.0mn/aPE81.6xn/a0%
8049Jilin Province Huinan Changlong Bio-pharmacyHK$1.033.0%-6.4%HK$577.1mn/aPE3.2xn/a10.2%
2161JBM (Healthcare)HK$0.7114.5%-38.3%HK$634.5mn/aPE25.8xn/an/a
1652Fusen PharmaceuticalHK$0.943.3%-62.4%HK$712.9mn/aPE36.8xn/a1.1%
3737Zhongzhi Pharmaceutical HoldingsHK$0.830%-40.3%HK$716.8mn/aPE11.8xn/a0%
950Lee's Pharmaceutical HoldingsHK$1.902.2%-53.2%HK$1.1bHK$2.10PE0.6xS8.7%3.2%
6118Austar LifesciencesHK$2.38-2.9%-86.6%HK$1.2bn/aPE3.8xn/a0%
1228CANbridge PharmaceuticalsHK$3.25-2.4%n/aHK$1.4bHK$12.37PS38xE17.0%n/a
2633Jacobson PharmaHK$0.8114.1%28.6%HK$1.6bn/aPE8.7xn/a4.8%
Page 1 of 4